Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antengene Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate ATG-017 in Combination with Opdivo® (nivolumab) in Advanced Solid Tumors 2021-12-13 08:30
Innovent and IASO Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting 2021-12-13 08:00
StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer 2021-12-13 07:00
Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant 2021-12-12 18:50
Phase 3 Data Show That TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-12-12 09:00
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP) 2021-12-10 23:38
Concord Medical Reports Financial Results for the First Half of 2021 2021-12-10 18:39
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx 2021-12-10 15:15
CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies 2021-12-10 15:11
Research shows Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19 2021-12-10 12:49
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan 2021-12-10 12:17
Össur hf: CEO Retirement and Succession Plan 2021-12-10 07:03
Cordis Names George Adams, MD as Chief Medical Officer 2021-12-09 23:00
AnchorDx Achieves Academic Breakthrough with Deep Methylation Representation Learning Research Paper Accepted by 36th AAAI Conference 2021-12-09 22:00
Trajan to acquire LEAP PAL Parts 2021-12-09 21:00
The innovative software "CAAS vFFR" by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness of the vessel Fractional Flow Reserve (vFFR) guided revascularization as compared to conventional FFR guided revascularization 2021-12-09 21:00
I-Mab to Hold Investor Call to Present In-depth Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma 2021-12-09 21:00
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube 2021-12-09 20:18
Sciwind Biosciences Completes Enrollment in Phase 2 Clinical Trial of XW003 in Type 2 Diabetes Patients 2021-12-09 20:00
Another clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer 2021-12-09 16:58
1 307 308 309 310 311 893